Anne Dyhl-Polk
- Oncology top 5%
- Cancer Treatment and Pharmacology 8
- Colorectal Cancer Treatments and Studies 5
- Cancer Immunotherapy and Biomarkers 4
-
- Chemotherapy-induced cardiotoxicity and mitigation 7
-
- Advanced Breast Cancer Therapies 3
-
- Chronic Lymphocytic Leukemia Research 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- Shoulder Injury and Treatment 2
Anne Dyhl-Polk
18 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Oncology 654
- Cardiology and Cardiovascular Medicine 393
- Cancer Research 125
- Immunology 150
- Pulmonary and Respiratory Medicine 200
Countries citing papers authored by Anne Dyhl-Polk
This map shows the geographic impact of Anne Dyhl-Polk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Dyhl-Polk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Dyhl-Polk more than expected).
Fields of papers citing papers by Anne Dyhl-Polk
This network shows the impact of papers produced by Anne Dyhl-Polk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Dyhl-Polk. The network helps show where Anne Dyhl-Polk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anne Dyhl-Polk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 28 | |
| 4 | 2021 | 15 | |
| 5 | 2020 | 9 | |
| 6 | 2020 | 34 | |
| 7 | 2020 | 1 | |
| 8 | 2020 | 24 | |
| 9 | 2019 | 165 | |
| 10 | 2019 | 53 | |
| 11 | 2018 | 37 | |
| 12 | 2017 | 55 | |
| 13 | 2017 | 106 | |
| 14 | 2016 | 45 | |
| 15 | 2016 | 31 | |
| 16 | 2014 | 185 | |
| 17 | 2014 | 33 | |
| 18 | 2014 | 35 | |
| 19 | 2013 | 43 | |
| 20 | 2013 | 229 |
About Anne Dyhl-Polk
Anne Dyhl-Polk is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Genetics, Hepatology and Dermatology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Colorectal Cancer Treatments and Studies (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Advanced Breast Cancer Therapies (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Shoulder Injury and Treatment (2 papers). The work is most often cited by research in Oncology (654 citations), Cardiology and Cardiovascular Medicine (393 citations), Cancer Research (125 citations), Immunology (150 citations) and Pulmonary and Respiratory Medicine (200 citations). Anne Dyhl-Polk has collaborated with scholars based in Denmark and Malaysia. Frequent co-authors include Dorte Nielsen, Kirsten Vistisen, Merete Vaage‐Nilsen, Inna M. Chen, Inge Marie Svane, Michael Andersson, Stig Brorson, Jeppe Vejlgaard Rasmussen, Bo Sanderhoff Olsen and Finn Ole Larsen. Their work appears in journals such as Cancer Treatment Reviews, Acta Orthopaedica, Acta Oncologica, BMJ Open and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.